Kisspeptin-10 has no single legal status. It depends on the product and how it is supplied.
No FDA-approved Kisspeptin-10 product was identified in the United States as reviewed August 30, 2026. A research use only label does not make a product approved for people.
Pharmacy mixing (compounding): FDA lists it in Category 2 for possible safety risks (FDA page dated April 22, 2026).
Sports: the anti-doping rules we checked list it as prohibited (checked August 30, 2026). Applies to male athletes only.
Rules for buying, selling, and prescribing also depend on how a product is made and sold, and on state law.
This is not legal advice.
Whether you may buy, sell, or use a product also depends on pharmacy (compounding) rules, a prescription, and state law. Read how U.S. peptide law works.
The record found no FDA-approved product. A label that says research use only does not make a product approved for people.
What the record says: No FDA-approved Kisspeptin-10 product was identified in the United States as reviewed August 30, 2026
Is it on FDA's compounding safety list?
Category 2: safety risk
Listed under the 503A policy.
FDA placed it here because it may present significant safety risks in compounding, pending further review. Each entry names the policy it falls under: 503A covers pharmacies, and 503B covers outsourcing facilities.
For covered male athletes, the 2026 WADA list prohibits kisspeptin and its agonist analogues at all times. This page is not personal clearance to compete.
Checked . Read the rule we checked. Check the current World Anti-Doping Agency list and your sport's rules before you compete.
Other names in this record: KP-10, KP10, Kisspeptin 112-121, Metastin 45-54, Human metastin 45-54.
Go further
Read the full Kisspeptin-10 record
What it is, what studies in people show, and what is still unknown.